✦ LIBER ✦
Raloxifene, an oestrogen-receptor-β-targeted therapy, inhibits androgen-independent prostate cancer growth: results from preclinical studies and a pilot phase II clinical trial
✍ Scribed by RONALD L. SHAZER; ANJALI JAIN; ANNA V. GALKIN; NADYA CINMAN; KOO N. NGUYEN; RONALD B. NATALE; MITCHELL GROSS; LELAND GREEN; LEON I. BENDER; STUART HOLDEN; LESLIE KAPLAN; DAVID B. AGUS
- Book ID
- 109052255
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 595 KB
- Volume
- 97
- Category
- Article
- ISSN
- 1464-4096
No coin nor oath required. For personal study only.